Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients-Reference-Cited by-同舟云学术

Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients

Published:2021-02-05 Issue:4 Volume:106 Page:563-573
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Rampotas Alexandros¹²^ORCID,Djebbari Faouzi¹^ORCID,Panitsas Fotios³,Lees Charlotte⁴,Tsagkaraki Ismini⁵,Gomes Ana Rita¹,Prideaux Steve⁶,Chen Lucia⁷,Prodger Catherine¹,Khera Akhil¹,Gray Nicola⁸,Ellis Lauren⁹,Sangha Gavinda¹,Lim Wen Yuen¹,Eyre Toby A.¹,Moore Sally¹,Ramasamy Karthik¹,Kothari Jaimal¹

Affiliation:

1. Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

2. Oxford University Clinical Academic Graduate School Oxford UK

3. Department of Haematology Laiko General Hospital Athens Greece

4. Royal Berkshire NHS Foundation Trust Reading UK

5. Buckinghamshire Healthcare NHS Trust Aylesbury UK

6. Great Western Hospitals NHS Foundation Trust Swindon UK

7. Milton Keynes University Hospital NHS Foundation Trust Milton Keynes UK

8. Wexham Park Hospital Slough UK

9. Frimley Health NHS Foundation Trust Frimley UK

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13588

Reference17 articles.

1. UK CR.Cancer statistics: Myeloma incidence statistics.2018.http://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/myeloma/incidence. Accessed April 04 2018.

2. Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

3. Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients

4. Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

5. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK;Infectious Diseases and Therapy;2024-04-24

2. Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant‐ineligible patients with myeloma who are treated with bortezomib‐based induction;European Journal of Haematology;2021-06-26

3. Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients;European Journal of Haematology;2021-02-05